Related references
Note: Only part of the references are listed.Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Julio A. Urbina
ACTA TROPICA (2010)
Case Report: Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus
Maria-Jesus Pinazo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults
Maria-Jesus Pinazo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Effects of Ravuconazole Treatment on Parasite Load and Immune Response in Dogs Experimentally Infected with Trypanosoma cruzi
Livia de Figueiredo Diniz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease
Yves Jackson et al.
CLINICAL INFECTIOUS DISEASES (2010)
An Estimate of the Burden of Chagas Disease in the United States
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2009)
Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Rodolfo Viotti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis
Jose A. Perez-Molina et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
J. Antonio Marin-Neto et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission
Sergio Sosa-Estani et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2009)
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
Jose Antonio Marin-Neto et al.
AMERICAN HEART JOURNAL (2008)
Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic
Joaquim Gascon et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2008)
The challenges of chagas disease -: Grim outlook or glimmer of hope?
Rick L. Tarleton et al.
PLOS MEDICINE (2007)
Evaluation and treatment of Chagas disease in the United States - A systematic review
Caryn Bern et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Pathogenesis of chronic Chagas heart disease
Jose Antonio Marin-Neto et al.
CIRCULATION (2007)
Predictors of mortality in chronic Chagas disease - A systematic review of observational studies
Anis Rassi et al.
CIRCULATION (2007)
Etiological treatment in patients infected by Trypanosoma cruzi:: experiences in Argentina
Sergio Sosa-Estani et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)
Jose A. Castro et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2006)
Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment - A nonrandomized trial
Rodolfo Viotti et al.
ANNALS OF INTERNAL MEDICINE (2006)
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations
S Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Respiratory syncytial virus - associated lower respiratory tract infections in hospitalized infants
C D'Elia et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2005)
Chagas disease: a role for autoimmunity?
RL Tarleton
TRENDS IN PARASITOLOGY (2003)
Risk progression to chronic Chagas cardiomyopathy:: influence of male sex and of parasitaemia detected by polymerase chain reaction
AL Basquiera et al.
HEART (2003)
Specific chemotherapy of Chagas disease: controversies and advances
JA Urbina et al.
TRENDS IN PARASITOLOGY (2003)
Pathogenesis of Chagas heart disease: role of autoimmunity
DM Engman et al.
ACTA TROPICA (2002)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Share Paper
